18 June 2013
Keywords: critical, therapeutics, submits, snda, fda, submitted, supplemental
Article | 11 April 2005
Critical Therapeutics has submitted a supplemental New Drug Application to the US Food and Drug Administration for its investigational asthma
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 July 2005
17 June 2013
© 2013 thepharmaletter.com